Bivastat 250mg Injection (bivalirudin): Comprehensive Medicine Guide
Clinical Reference Standards: CDSCO (Central Drugs Standard Control Organisation), Indian Pharmacopoeia (IP) & WHO | Last Updated: September 2026
When to Call Your Doctor IMMEDIATELY
- Severe or uncontrollable bleeding from any site
- Black, tarry stools or vomiting blood
- Sudden severe headache, confusion, or vision changes
- Difficulty breathing, chest pain, or rapid heartbeat
- Swelling of face, lips, tongue, or throat
- Decreased urine output or swelling in legs
- Unusual bruising or petechiae
If experiencing severe symptoms, call emergency services immediately.
What is bivacard 250mg injection used for?
Bivastat 250mg injection contains bivalirudin, a direct thrombin inhibitor used during percutaneous coronary intervention (PCI) and in patients with heparin-induced thrombocytopenia. It is given intravenously by a healthcare professional to prevent blood clots.
- Generic Name: Bivalirudin
- Manufacturer: Biocon
- Form: Allopathy
- Pregnancy Category: Consult doctor
- Prescription Required: Yes
🇮🇳 bivacard 250mg injection के बारे में (Hindi Summary)
उपयोग: यह दवा बाइवलिरुडिन 250 मिलीग्राम इंजेक्शन के रूप में उपलब्ध है, जिसका उपयोग अस्पताल में हृदय की कुछ प्रक्रियाओं के दौरान रक्त के थक्के बनने से रोकने के लिए किया जाता है। यह आमतौर पर पर्क्यूटेनियस कोरोनरी इंटरवेंशन (PCI) के दौरान और हेपरिन-प्रेरित थ्रोम्बोसाइटोपेनिया (HIT) वाले रोगियों में दिया जाता है। यह दवा केवल योग्य डॉक्टर या स्वास्थ्यकर्मी द्वारा नस के माध्यम से दी जाती है। इसे घर पर स्वयं न लगाएं।
साइड इफेक्ट्स: आम दुष्प्रभावों में इंजेक्शन स्थल पर रक्तस्राव, हल्की चोट, मतली, सिरदर्द और पीठ दर्द शामिल हैं। गंभीर दुष्प्रभावों में बड़े पैमाने पर रक्तस्राव, गंभीर एलर्जी प्रतिक्रिया और प्लेटलेट्स में कमी हो सकती है। यदि आपको असामान्य रक्तस्राव, काला मल, या गंभीर सिरदर्द हो तो तुरंत डॉक्टर को बताएं।
सुरक्षा सलाह: यह दवा केवल अस्पताल में प्रशिक्षित स्वास्थ्यकर्मी द्वारा दी जानी चाहिए। इसे स्वयं न लगाएं। अपने डॉक्टर को गुर्दे की समस्या, यकृत रोग, हाल ही में हुए रक्तस्राव, या गर्भावस्था के बारे में बताएं। इस दवा को लेते समय चोट लगने वाली गतिविधियों से बचें। डॉक्टर आपके रक्त की जांच और गुर्दे की कार्यप्रणाली की निगरानी करेंगे। बिना डॉक्टर की सलाह के कोई अन्य रक्त पतला करने वाली दवा न लें।
💊 bivacard 250mg injection Uses & Benefits
[{"condition":"Percutaneous coronary intervention (PCI)","description":"Used as an anticoagulant during PCI to prevent thrombus formation in patients with stable angina, unstable angina, or acute myocardial infarction.","evidence":"Well-established"},{"condition":"Heparin-induced thrombocytopenia (HIT)","description":"Used as an alternative anticoagulant in patients with HIT who require parenteral anticoagulation for procedures or treatment.","evidence":"Well-established"},{"condition":"Acute coronary syndromes","description":"May be used in the management of acute coronary syndromes in patients undergoing early invasive strategies.","evidence":"Established"}]
Off-label uses: [{"condition":"Anticoagulation in extracorporeal membrane oxygenation (ECMO)","description":"Sometimes used off-label for anticoagulation in patients on ECMO, though evidence is limited.","evidence":"Limited"},{"condition":"Anticoagulation in pediatric cardiac procedures","description":"Occasionally used off-label in pediatric patients undergoing cardiac catheterization, but dosing is not well established.","evidence":"Limited"}]
Primary treatment for: Percutaneous coronary intervention (PCI)
Also treats: Heparin-induced thrombocytopenia (HIT), Acute coronary syndromes
📋 Drug Information
| Generic Name(s) | Bivalirudin |
| Brand Name | Bivastat 250mg Injection |
| Manufacturer | Biocon |
| Packaging / Form | Varies by brand (Allopathy) |
| Therapeutic Class | CARDIAC |
| Action Class | Direct thrombin inhibitor- parenteral |
| Route of Administration | Intravenous (IV) only. Administered as a continuous infusion, often with an initial bolus |
| Storage | Store at 2°C to 8°C (36°F to 46°F) in the refrigerator. Do not freeze. Keep in the original carton to protect from light. Once reconstituted, the solution should be used immediately or stored as directed by the manufacturer. |
| Shelf Life | Refer to the product packaging for the expiration date. Do not use beyond the expiry date. |
| WHO Guideline | Not established from the available information. |
| ICMR Guideline | Not established from the available information. |
👨⚕️ Doctor's Practical Tips
Evidence-based practical advice from experienced clinicians
🔍 Is This Medicine Right for Your Symptom?
Educational reference. Always consult a doctor for diagnosis.
🔬 How This Medicine Works (Pharmacology)
Pharmacokinetics
How It Works
Bivalirudin is a synthetic 20-amino acid peptide that acts as a direct, specific, and reversible inhibitor of thrombin. It binds to both the catalytic site and the anion-binding exosite of thrombin, thereby blocking thrombin-mediated conversion of fibrinogen to fibrin and thrombin-induced platelet activation. Unlike heparin, bivalirudin does not require antithrombin III as a cofactor and is not neutralized by platelet factor 4, making it effective in patients with heparin-induced thrombocytopenia. Its action is concentration-dependent and reversible.
Mechanism Steps
💡 How to Take bivacard 250mg injection
Strength: Sterile lyophilized powder for injection, 250 mg per vial, to be reconstituted and diluted for intravenous infusion.
Dosage Information
| Adult Dosage | The dose of this medicine is individualized by a qualified clinician based on the indication, patient weight, renal function, and other factors. For percutaneous coronary intervention (PCI), a common regimen is an intravenous bolus of 0.75 mg/kg followed by a continuous infusion of 1.75 mg/kg/hour for the duration of the procedure. For patients with heparin-induced thrombocytopenia, dosing may differ. Dose must be individualized by a qualified clinician based on indication, age, weight, renal and hepatic function. |
| Pediatric Dosage | Pediatric dosing is not established from available information. Consult a pediatrician. |
| Elderly Dosage | Elderly patients may have reduced renal function, which can prolong the half-life of bivalirudin. Dose adjustment may be necessary based on creatinine clearance. Monitor closely for bleeding. |
| Renal Impairment | In patients with severe renal impairment (CrCl <30 mL/min), the infusion rate should be reduced. For PCI, a common adjustment is to reduce the infusion rate to 1 mg/kg/hour. For patients on hemodialysis, the dose may need further adjustment. Consult a nephrologist or clinical pharmacist for specific dosing. |
| Hepatic Impairment | No specific dose adjustment is recommended for hepatic impairment. However, monitor liver function and bleeding signs. |
| Maximum Daily Dose | The maximum daily dose is not fixed and depends on the indication, patient weight, and renal function. It is determined by the prescribing clinician. |
Dosage Timeline
🍽️ Food Timing Guide
⏰ What to Do If You Miss a Dose
⚠️ Side Effects of bivacard 250mg injection
✅ Common Side Effects
🚨 Serious Side Effects
⚠️ Rare Side Effects
Consult your doctor if you experience any unusual symptoms.
🔬 Drug Interactions
| Drug | Severity | Effect |
|---|---|---|
| Warfarin | Major | |
| DOACs | Major | |
| Thrombolytics | Major | |
| GP IIb/IIIa inhibitors | Major | |
| NSAIDs | Moderate | |
| SSRIs/SNRIs | Moderate | |
| Corticosteroids | Moderate | |
| Antiplatelet agents | Minor | |
| Herbal supplements (ginkgo, garlic) | Minor | |
| Alcohol | Moderate |
🚨 Major Interactions
- Warfarin
- Direct oral anticoagulants (DOACs)
- Thrombolytic agents (e.g., alteplase)
- Glycoprotein IIb/IIIa inhibitors (e.g., abciximab)
⚡ Moderate Interactions
- NSAIDs (e.g., ibuprofen, naproxen)
- SSRIs/SNRIs
- Corticosteroids
🍷 Alcohol Interaction
Alcohol may increase the risk of gastrointestinal bleeding and should be avoided while receiving this medicine. Consult your doctor for personalized advice.
🔎 Check Your Other Medicines
Educational tool. Always confirm with your doctor or pharmacist.
🛡️ Safety & Warnings
🚫 Contraindications
["Active major bleeding","Severe uncontrolled hypertension","Known hypersensitivity to bivalirudin or any component of the formulation","Severe renal impairment (CrCl
⚠️ Warnings & Precautions
["Bleeding risk: Bivalirudin increases the risk of bleeding. Monitor closely, especially in patients with renal impairment or those receiving other anticoagulants.","Renal impairment: Dose reduction is required for patients with CrCl
🤱 Lactation Safety
It is not known whether bivalirudin is excreted in human breast milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
💊 Overdose Management
There is no specific antidote for bivalirudin overdose. In case of overdose, discontinue the infusion immediately and monitor the patient closely for signs of bleeding. Supportive care should be provided. Bivalirudin is dialyzable; hemodialysis may be considered in severe cases with renal impairment. Contact a poison control center or emergency services immediately.
⏰ Missed Dose
This medicine is administered by a healthcare professional in a controlled setting. If you miss a scheduled dose, inform your healthcare provider immediately. Do not attempt to self-administer or double the dose.
Additional Safety Advice
This medicine must be administered only by a healthcare professional in a hospital or clinic equipped to monitor and manage bleeding complications. Do not attempt to self-administer. Inform your doctor if you have kidney problems, liver disease, recent bleeding, or are pregnant or breastfeeding. Avoid activities that increase bleeding risk, such as contact sports or using sharp objects, while receiving this medicine. Your doctor will monitor your blood counts, kidney function, and signs of bleeding during treatment. Do not take any other blood-thinning medicines without consulting your doctor. If you miss a dose, inform your healthcare provider immediately; do not try to catch up on your own.
👴 Special Considerations for Elderly
💡 For Patients Above 65
Elderly patients are more likely to have reduced renal function, which can prolong the half-life of bivalirudin and increase bleeding risk. Dose adjustment based on creatinine clearance is essential. Monitor closely for bleeding and renal function.
🤰 Pregnancy Planning (TTC)
If you are planning pregnancy, consult your doctor before receiving this medicine. Bivalirudin is Pregnancy Category B, but use only if clearly needed. Discuss risks and benefits with your healthcare provider.
🏥 Post-Surgery Considerations
After surgery, bivalirudin may be used to prevent clots, but bleeding risk must be balanced. Monitor surgical site for bleeding and follow your surgeon's instructions.
🦷 Dental Procedures
Inform your dentist if you are receiving or have recently received bivalirudin, as it increases bleeding risk. Dental procedures may need to be postponed or managed with caution.
💚 Lifestyle Tips for Better Results
🏋️ Exercise Considerations
Avoid strenuous exercise or activities that could cause injury while on this medicine, as bleeding risk is increased. Light activity is generally safe, but consult your doctor before starting any exercise program.
🥗 Diet Recommendations
💼 Impact on Daily Work & Life
This medicine is given in a hospital setting, so it may require a short hospital stay. After discharge, you may need to avoid driving or operating heavy machinery if you feel dizzy or weak. Follow your doctor's advice regarding return to work.
🛑 When to Stop This Medicine
Do not stop this medicine without consulting your doctor. It is usually stopped by the healthcare provider after the procedure or when anticoagulation is no longer needed. If you experience severe bleeding or allergic reactions, seek immediate medical attention.
📅 Long-Term Use Effects
Bivalirudin is typically used for short durations during procedures or acute care. Long-term effects are not well studied because it is not intended for chronic use. Prolonged use may increase bleeding risk and require monitoring of renal function and platelet counts. When used in HIT, it is continued until alternative anticoagulation is established.
🌿 Non-Medicine Approaches
These can complement medicine but do not replace prescribed treatment.
Alternative anticoagulant, but contraindicated in HIT.
Evidence: Well-establishedAnother direct thrombin inhibitor used in HIT.
Evidence: Well-establishedFactor Xa inhibitor, but not recommended for PCI due to lack of efficacy data.
Evidence: Limited💉 Vaccination Considerations
💉 If You're Getting Vaccinated
No specific vaccine interactions are known. However, inform your doctor about your vaccination status and any recent vaccinations.
📦 Storage Guide
✅ DO
Store in refrigerator at 2°C to 8°C
❌ DON'T
Do not freeze
✅ DO
Keep in original carton to protect from light
❌ DON'T
Do not use if solution is discolored or contains particles
✅ DO
Use reconstituted solution immediately as directed
❌ DON'T
Do not store reconstituted solution for extended periods unless specified
✈️ Traveling with This Medicine
This medicine is administered in a hospital setting and is not for self-administration during travel. If you are traveling after treatment, carry a copy of your prescription and medical records. Inform your doctor before travel, especially if you have renal impairment. Store the medicine as directed if you are carrying it, but it is unlikely to be needed outside a medical facility.
💰 Cost Analysis & Savings
👥 Real Patient Stories
Educational, anonymized scenarios. Individual results may vary.
💬 Questions Patients Often Ask
A: This medicine starts working immediately after intravenous administration, within minutes.
A: It is given intravenously by a healthcare professional, usually as a bolus followed by a continuous infusion.
A: Common side effects include bleeding from the injection site, nausea, headache, and back pain.
A: It is Pregnancy Category B. Use only if clearly needed, as determined by your doctor.
A: No, this medicine must be administered by a healthcare professional in a hospital or clinic setting.
🤔 Common Patient Concerns
🔄 Substitutes for bivacard 250mg injection
View AllAlternative brands with exact same active ingredient:
-
bivamax 250mg injectionLupin Ltd ₹5,089.59 36.7% CHEAPER
-
gennomax 250mg injectionEmcure Pharmaceuticals Ltd ₹5,860.00 27.1% CHEAPER
-
bivaflo 250mg injectionSun Pharmaceutical Industries Ltd ₹5,896.88 26.6% CHEAPER
-
bivastat 250mg injectionCipla Ltd ₹6,496.88 19.1% CHEAPER
-
Flopace 250mg InjectionSun Pharmaceutical Industries Ltd ₹7,107.80 11.5% CHEAPER
Medical Note: Always consult your doctor before switching medications.
🛑 Myths vs. Facts
- Myth: Bivastat 250mg injection can be self-administered at home.
Fact: This medicine must be given by a healthcare professional in a hospital setting. - Myth: Bivastat 250mg injection is the same as heparin.
Fact: Bivalirudin is a direct thrombin inhibitor, while heparin works via antithrombin III. They have different mechanisms and uses. - Myth: Bivastat 250mg injection has no bleeding risk.
Fact: Like all anticoagulants, bivalirudin increases the risk of bleeding, and patients must be monitored closely.
🔄 Alternative Options
Generic Alternatives
- Bivalirudin
Brand Alternatives
- Angiomax